NASDAQ:PMCB | Cash Flow Statement | PharmaCyte Biotech, Inc.

Complete source-backed cash-flow history.

Available history
2010-10-31 to 2026-04-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-04-30-$4.39M-$1.39M$0.00$0.00-$169,818.00
2026-01-31$746,860.00
2025-10-31-$7.42M
2025-07-31-$8.36M-$1.99M$0.00$0.00$0.00
2025-04-30$11.75M-$1.04M$0.00$171,543.00-$171,543.00
2025-01-31-$3.05M
2024-10-31-$1.47M
2024-07-31$23.42M-$373,297.00-$7M$742,179.00-$10.17M
2024-04-30$1.35M-$332,958.00$0.00$1.17M-$10.7M
2024-01-31-$619,537.00$404,717.00
2023-10-31$2.79M$164,953.00
2023-07-31-$3.18M$342,959.00$0.00$26.46M$6.28M
2023-04-30-$126,338.00-$288,388.00$0.00$4.31M-$4.31M
2023-01-31-$764,136.00
2022-10-31-$1.88M
2022-07-31-$1.55M-$1.08M$0.00$2.09M-$2.09M
2022-04-30-$1.42M-$1.19M$0.00$0.00-$50,805.00
2022-01-31-$811,290.00
2021-10-31-$979,746.00
2021-07-31-$1.03M-$1.24M$0.00$0.00$0.00
2021-04-30-$960,004.00-$940,303.00$0.00$50,805.00
2021-01-31-$757,096.00
2020-10-31-$950,192.00
2020-07-31-$883,944.00-$551,002.00$0.00$1.82M
2020-04-30-$750,383.00-$639,392.00$0.00$1.39M
2020-01-31-$875,308.00
2019-10-31-$1.07M
2019-07-31-$1.13M-$763,140.00$0.00$582,500.00
2019-04-30-$1.14M-$661,363.00$0.00$482,500.00
2019-01-31-$676,347.00
2018-10-31-$1.04M
2018-07-31-$1.22M-$622,243.00$0.00$1.4M
2018-04-30-$1.3M-$1.37M$0.00$930,000.00
2018-01-31-$2.03M
2017-10-31-$1.81M
2017-07-31-$1.69M-$935,567.00$0.00$1.75M
2017-04-30-$1.16M-$800,887.00$0.00$1.8M
2017-01-31-$1.28M
2016-10-31-$974,551.00
2016-07-31-$1.03M-$906,928.00$0.00$1.33M
2016-04-30-$1.12M-$1.22M
2016-01-31-$1.79M
2015-10-31-$1.64M
2015-07-31-$1.52M-$1.06M
2015-04-30-$2.82M-$1.09M
2015-01-31-$1.46M
2014-10-31-$4.06M
2014-07-31-$1.58M-$786,814.00
2014-04-30-$16.47M-$938,240.00
2014-01-31-$458,772.00
2013-10-31-$5.66M
2013-07-31-$4.67M-$159,674.00-$1.57M$1.74M
2013-04-30-$327,173.00-$142,951.00-$165,000.00$473,920.00
2013-01-31-$376,843.00
2012-10-31-$382,816.00
2012-07-31-$510,517.00-$85,388.00-$195,750.00$289,757.00
2012-04-30-$504,363.00-$51,955.00-$191,730.00$220,331.00
2012-01-31-$271,779.00
2011-10-31-$437,152.00
2011-07-31-$686,020.00-$119,627.00-$320,000.00$465,500.00
2011-04-30-$1.09M-$141,871.00$195,458.00
2011-01-31-$124,101.00
2010-10-31-$45,820.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-04-30-$19.42M-$5.15M$2M$401,625.00$6.58M
2025-04-30$30.66M-$2.98M-$7M$2.54M-$25.03M
2024-04-30$333,763.00-$2.15M-$5M$28.2M-$10.71M
2023-04-30-$4.32M-$3.79M$0.00$13.56M-$13.56M
2022-04-30-$4.24M-$4.12M$0.00$0.00$87.31M
2021-04-30-$3.55M-$3.33M$0.00$4.64M
2020-04-30-$3.83M-$2.34M$0.00$2.73M
2019-04-30-$4.07M-$2.88M$0.00$2.34M
2018-04-30-$6.83M-$5.08M$0.00$2.68M
2017-04-30-$4.44M-$3.34M$0.00$4.88M
2016-04-30-$6.06M-$4.35M
2015-04-30-$9.93M-$4.56M
2014-04-30-$27.25M-$1.55M
2013-04-30-$1.6M-$390,426.00-$646,750.00$1.22M
2012-04-30-$1.9M-$259,289.00-$871,730.00$1.09M
2011-04-30-$1.4M-$225,232.00$281,717.00